Forte Biosciences
- Pharmaceutical Preparations
- Dallas, Texas
Compensation history
Top executives at Forte Biosciences received an average of $2M per person in annual compensation from 2016 to 2023.
By year
Executives
We found seven executives who work or worked at Forte Biosciences.
Paul Wagner
Forte Biosciences
Chief Executive Officer
Antony Riley
Forte Biosciences
Chief Financial Officer
Marty Duvall
Forte Biosciences
Chief Executive Officer
Mark Foletta
Forte Biosciences
Chief Financial Officer
Martin Duvall
Forte Biosciences
Chief Executive Officer
Douglas Jolly
Forte Biosciences
Executive Vice President, Research and Pharmaceutical Development
Asha Das
Forte Biosciences
Chief Medical Officer
News
Forte Biosciences CEO Paul Wagner's 2023 pay rises 18% to $1.5M
December 31, 2024
Forte Biosciences CEO Paul Wagner's 2021 pay jumps 597% to $5.4M
April 29, 2022
Forte Biosciences CEO Marty Duvall's 2020 pay falls 34% to $1.2M
April 30, 2021
Forte Biosciences CEO Martin Duvall's 2018 pay falls 54% to $2M
April 19, 2019
About Forte Biosciences
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 3060 Pegasus Park Drive, Building 6, Dallas, Texas 75247
- (310) 618-6994
- December 31
- Former names
- Tocagen Inc